CIM
EW icon

Calvert Investment Management’s Edwards Lifesciences EW Stock Holding History

Calvert Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40,953
Closed -$1.28M – 201
2016
Q4 		$1.28M Sell
40,953
-702
-2% -$22.7K 0.05% 343
2016
Q3 		$1.67M Buy
41,655
+2,484
+6% +$93.5K 0.06% 310
2016
Q2 		$1.3M Buy
39,171
+1,443
+4% +$49.4K 0.05% 320
2016
Q1 		$1.11M Buy
37,728
+1,482
+4% +$40.9K 0.05% 306
2015
Q4 		$954K Sell
36,246
-329,508
-90% -$8.56M 0.04% 306
2015
Q3 		$8.67M Sell
365,754
-11,610
-3% -$280K 0.43% 61
2015
Q2 		$8.96M Buy
377,364
+186,762
+98% +$4.21M 0.4% 66
2015
Q1 		$4.53M Sell
190,602
-246,720
-56% -$5.53M 0.29% 100
2014
Q4 		$9.28M Buy
437,322
+1,740
+0.4% +$35K 0.64% 44
2014
Q3 		$7.42M Buy
+435,582
New +$6.88M 0.55% 57

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Calvert Investment Management's EW Position: Q1 2017 in Review

Calvert Investment Management sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 40,953 shares — an estimated $1.28M sold.

Calvert Investment Management first reported a position in EW in Q3 2014 and held it in 10 quarters. The position peaked at $9.28M in Q4 2014. 690 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Calvert Investment Management reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 40,953 Edwards Lifesciences shares in Q1 2017, an estimated $1.28M.
  • Calvert Investment Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 10 quarters.
  • Calvert Investment Management's Edwards Lifesciences position peaked at $9.28M in Q4 2014.
  • 690 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.